Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4959786 | 6009726 | F | 4959786-X | 20060211 | 20060321 | 20060331 | EXP | CO-BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.-2006-BP-03172CL | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 63 | YR | F | Y | 157 | KG | 20060331 | MD | 20060213 | COLOMBIA |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
4959786 | 1007117975 | PS | SPIRIVA | 1 | RESPIRATORY (INHALATION) | NR | 21395 | ||||
4959786 | 1007117976 | C | METOPROLOL | 2 | ORAL | ||||||
4959786 | 1007117977 | C | LOVASTATINA | 2 | ORAL | ||||||
4959786 | 1007117978 | C | ASPIRIN | 1 | ORAL |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
4959786 | 1007117975 | CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
4959786 | 1007117976 | HYPERTENSION |
4959786 | 1007117977 | DYSLIPIDAEMIA |
4959786 | 1007117978 | DYSLIPIDAEMIA |
Outcome of event
Event ID | OUTC COD |
---|---|
4959786 | DE |
Reactions reported
Event ID | PT |
---|---|
4959786 | CANDIDIASIS |
4959786 | CARDIAC FAILURE |
4959786 | RESPIRATORY FAILURE |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
4959786 | 1007117975 | 20060113 | |||
4959786 | 1007117976 | 20050101 | |||
4959786 | 1007117977 | 20050101 | |||
4959786 | 1007117978 | 20050101 |